Word

RECOMBUMIN

Status

Registered

Status Code

700

Status Date

Tuesday, April 23, 2024

Serial Number

79345867

Registration Number

7362015

Registration Date

Tuesday, April 23, 2024

Mark Type

4

Filing Date

Thursday, May 26, 2022

Published for Opposition

Tuesday, February 6, 2024

Trademark Owner History

Albumedix Ltd - Original Registrant

Classifications

5 Pharmaceuticals for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; pharmaceutical products and substances for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; albumin, chemical preparations, synthetic peptides, protein supplements, monoclonal, polyclonal, immunological, native and recombinant antibodies for medical and veterinary use, cells for medical and veterinary use, viruses, live viruses, live- attenuated viruses, attenuated viruses, and virus-like particles and viral vectors for medical and veterinary use, vaccines, growth factors for medical and veterinary use, immune modulators for medical and veterinary use, monoclonal antibodies, biological tissue and tissue cultures, recombinant proteins for medical and veterinary use, nucleic acid sequences, blood plasma, blood components for medical and veterinary use, all being for pharmaceutical use for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; reagents for medical use; diagnostic reagents for medical use; protein supplements for pharmaceutical purposes; albuminous preparations for medical or veterinary purposes; recombinant albumin for biological therapeutic purposes

1 Chemicals used in industry, science and for use in the manufacture of pharmaceuticals; chemical reagents other than for medical or veterinary purposes; diagnostic reagents and preparations, other than for medical or veterinary purposes; chemical excipients for use in the manufacture of pharmaceutical preparations; proteins for industrial purposes; recombinant human albumin for use as a stabilizer and excipient for industrial purposes and for use in the manufacture of cell culture media, cell and tissue storage and preservation media and for the manufacture of diagnostic imaging agents; cell culture reagents for scientific and research use, and chemical preservation reagents for scientific and research use; albumin for use in the manufacture of pharmaceutical products, vaccines, cellular therapies, regenerative medicines and gene therapies; protein in raw material form for scientific and medical research

Trademark Events

Mar 7, 2023

Assigned To Examiner

Jul 21, 2022

Sn Assigned For Sect 66a Subseq Desig From Ib

Jul 27, 2022

Limitation From Original Application Entered

Jul 29, 2022

New Application Office Supplied Data Entered

Aug 2, 2022

Application Filing Receipt Mailed

Jan 29, 2023

New Representative At Ib Received

Mar 15, 2023

Non-Final Action Written

Mar 16, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Apr 2, 2023

New Representative At Ib Received

May 3, 2023

Refusal Processed By Mpu

May 3, 2023

Non-Final Action Mailed - Refusal Sent To Ib

May 23, 2023

Refusal Processed By Ib

Nov 3, 2023

Teas Response To Office Action Received

Nov 3, 2023

Correspondence Received In Law Office

Nov 3, 2023

Teas/Email Correspondence Entered

Dec 27, 2023

Notification Of Possible Opposition Sent To Ib

Dec 27, 2023

Notification Of Possible Opposition Created, To Be Sent To Ib

Jan 13, 2024

Notification Of Possible Opposition - Processed By Ib

Dec 31, 2023

Approved For Pub - Principal Register

Jan 17, 2024

Notification Of Possible Opposition Sent To Ib

Jan 17, 2024

Notification Of Notice Of Publication E-Mailed

Jan 17, 2024

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Feb 5, 2024

Notification Processed By Ib

Feb 6, 2024

Published For Opposition

Feb 6, 2024

Official Gazette Publication Confirmation E-Mailed

Apr 23, 2024

Registered-Principal Register

Apr 23, 2024

Notice Of Registration Confirmation Emailed